We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    NCT00445874
Previous Study | Return to List | Next Study

Evaluation of Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens in the Treatment of Allergic Conjunctivitis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00445874
Recruitment Status : Completed
First Posted : March 9, 2007
Last Update Posted : April 9, 2009
Information provided by:
Vistakon Pharmaceuticals

Brief Summary:
The purpose of this study is to evaluate the efficacy and safety of an anti-allergy drug with a contact lens compared to placebo in preventing ocular itching associated with allergic conjunctivitis

Condition or disease Intervention/treatment Phase
Allergic Conjunctivitis Drug: Ketotifen with a Contact Lens (no generic name) Phase 3

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 120 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double
Official Title: A Multi-Center, Randomized, Double-Masked, Placebo-Controlled Evaluation of the Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens as Compared to Placebo in the Prevention of Allergic Conjunctivitis in a Population of Allergic Contact Lens Wearers
Study Start Date : February 2007
Actual Study Completion Date : May 2007

Resource links provided by the National Library of Medicine

Primary Outcome Measures :
  1. Ocular itching

Secondary Outcome Measures :
  1. Conjunctival, ciliary, and episcieral redness; chemosis and mucous discharge; tearing and lid swelling

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   8 Years and older   (Child, Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • History of ocular allergies and a positive skin test reaction to cat hair, cat dander, grasses, ragweed, and/or trees withing the past 24 months
  • Successful soft contact lens wearer who has frequently worn contact lenses for at least one month or more

Exclusion Criteria:

  • Active ocular infection
  • Clinically significant blepharitis
  • Follicular conjunctivitis
  • Pterygium
  • Narrow angle glaucoma
  • Dry eye dyndrome
  • Ocular surgery within past 6 months
  • Pregnancy or lactation

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00445874

Layout table for location information
United States, Arizona
Phoenix, Arizona, United States, 85032
Phoenix, Arizona, United States
United States, California
Irvine, California, United States
United States, Massachusetts
North Andover, Massachusetts, United States
United States, Ohio
Cincinnati, Ohio, United States
Fairfield, Ohio, United States
Mason, Ohio, United States
Sponsors and Collaborators
Vistakon Pharmaceuticals
Layout table for investigator information
Study Director: Brian Pall, OD, MS, FAAO Vistakon Pharmaceutical
Layout table for additonal information
ClinicalTrials.gov Identifier: NCT00445874    
Other Study ID Numbers: 06-003-23
First Posted: March 9, 2007    Key Record Dates
Last Update Posted: April 9, 2009
Last Verified: April 2009
Keywords provided by Vistakon Pharmaceuticals:
allergic conjunctivitis, ophthalmology, multicenter, controlled
Additional relevant MeSH terms:
Layout table for MeSH terms
Conjunctivitis, Allergic
Immune System Diseases
Conjunctival Diseases
Eye Diseases
Hypersensitivity, Immediate
Dermatologic Agents
Histamine H1 Antagonists
Histamine Antagonists
Histamine Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action
Physiological Effects of Drugs
Anti-Allergic Agents